Nolato AB Class B (SE:NOLA.B)
:NOLA.B
Want to see SE:NOLA.B full AI Analyst Report?
Top Page
Nolato AB
(NOLA.B)
Select Model
Select Model
Rating:58Neutral
Price Target:
kr50.00
▼(-18.30% Downside)
Action:Reiterated
Date:06/05/26
The score is driven primarily by solid underlying financial quality (healthy margins and a conservative, improving balance sheet) but is held back by weak technical trend signals and volatile cash-flow conversion. Valuation and dividend yield provide moderate support.
Positive Factors
Healthy margins
Sustained gross and net margins around historical TTM levels indicate persistent pricing power, manufacturing efficiency, and cost control. Margins at these levels provide durable earnings support, buffer cyclical revenue swings, and enable reinvestment in tooling, quality systems and customer programs.
Negative Factors
Stagnant revenue growth
Top-line flat to slightly down constrains scalability of fixed-cost leverage and limits prospects for meaningful earnings expansion. Without sustained revenue momentum or new program wins, growth-dependent investments and returns may be muted, making future margin gains harder to achieve.
Read all positive and negative factors
Positive Factors
Negative Factors
Healthy margins
Sustained gross and net margins around historical TTM levels indicate persistent pricing power, manufacturing efficiency, and cost control. Margins at these levels provide durable earnings support, buffer cyclical revenue swings, and enable reinvestment in tooling, quality systems and customer programs.
Read all positive factors
Nolato AB (NOLA.B) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr13.05B
Dividend Yield2.48%
Average Volume (3M)189.00K
Price to Earnings (P/E)17.2
Beta (1Y)0.82
Revenue Growth-3.19%
EPS Growth9.21%
CountrySE
Employees5,405
SectorHealthcare
Sector Strength45
IndustryConglomerates
Share Statistics
EPS (TTM)2.82
Shares Outstanding241,786,940
10 Day Avg. Volume114,289
30 Day Avg. Volume189,000
Financial Highlights & Ratios
PEG Ratio1.19
Price to Book (P/B)3.01
Price to Sales (P/S)1.76
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)3
Revenue Forecast (FY)kr9.71B
Nolato AB Business Overview & Revenue Model
Company Description
Nolato AB (publ) is a Swedish enterprise that specializes in the creation, manufacturing, and commercialization of polymer-based products, utilizing plastics, silicones, and thermoplastic elastomers. Its extensive portfolio serves a diverse array ...
How the Company Makes Money
Nolato makes money mainly by providing contract manufacturing and related development services to B2B customers, earning revenue from the sale of produced components, assemblies, and integrated manufacturing solutions. Key revenue streams generall...
Nolato AB Earnings Call Summary
Earnings Call Date:Feb 05, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:Jul 17, 2026
Earnings Call Sentiment Positive
The call conveyed a broadly positive strategic and financial picture for the full year—sales growth, a double-digit increase in operating profit for the year, improved margins, higher EPS, a larger dividend, strong cash generation, improved ROCE and notable sustainability achievements. Near-term Q4-specific headwinds (currency effects, start-up costs, year-end volume weakness and volatile precious metal prices) weighed on quarterly results and will partially carry into Q1 2026, but management characterized these as temporary and actionable (pricing adjustments, ongoing ramp-ups, and planned expansions). Overall, the highlights (annual profitability and margin improvement, medical growth, sustainability milestones and financial strength enabling M&A) outweigh the temporary lowlights.Positive Updates
Q4 Sales Growth (Currency-Adjusted)
Net sales of SEK 2.272 billion in Q4, representing approximately 2% growth adjusted for currency headwinds (company-stated).
Negative Updates
Q4 EBITA Slightly Below Prior Year and Currency Headwinds
Operating profit (EBITA) in Q4 was SEK 236 million vs SEK 240 million prior year; reported currency headwinds were sizable (management cited ~6% and CFO cited 7%), negatively impacting reported results and representing an accelerating negative effect (approx. SEK 14 million in Q4).
Read all updates
Q4-2025 Updates
Positive
Negative
Q4 Sales Growth (Currency-Adjusted)
Net sales of SEK 2.272 billion in Q4, representing approximately 2% growth adjusted for currency headwinds (company-stated).
Read all positive updates
Company Guidance
Management guided that Q4 sales were just shy of SEK 2.3bn (net sales SEK 2,272m) with ~2% currency-adjusted growth but a 7% FX headwind, EBITA of SEK 236m (vs SEK 240m) and an EBITA margin of 10.4% for the quarter (FY margin 11.3% vs 9.9% in 2024, +1.4pp), noting full‑year 2025 sales close to SEK 9.5bn, EPS SEK 2.88, a proposed dividend of SEK 1.70 (payout 59% vs 61%), and a strong balance sheet enabling M&A; Medical Solutions (58% of group) delivered just above SEK 1.3bn (+5% adj.) with an 11.6% margin (+0.4pp) while Engineered (42% of group) was close to SEK 1bn with materials up ~10% adj. but a 100bp negative hit (largely from silver pricing and customer shutdowns); temporary headwinds (US start‑up costs ~‑0.5pp on medical, lower year‑end volumes, higher precious metal costs) reduced Q4 by ~SEK 25–30m vs Q3 and will partly carry into Q1, which management expects to be a more normalized quarter as pricing actions take effect; cash flow from operations was SEK 310m, Q4 CapEx SEK 146m, FY2026 CapEx guided SEK 650–700m (≈SEK 100m remaining for Hungary), ROCE 14.2%, and sustainability progress includes a 96% reduction in Scope 1–2 and 30% reduction in upstream Scope 3 (base year 2021) with a science‑based Net‑Zero 2045 approval.Nolato AB Financial Statement Overview
Summary
Income Statement
68
Positive
Balance Sheet
78
Positive
Cash Flow
52
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.37B | 9.46B | 9.66B | 9.55B | 10.77B | 11.61B |
| Gross Profit | 1.71B | 1.73B | 1.61B | 1.34B | 1.43B | 1.82B |
| EBITDA | 1.57B | 1.59B | 1.51B | 1.28B | 1.48B | 1.92B |
| Net Income | 759.00M | 777.00M | 658.00M | 435.00M | 697.00M | 1.16B |
Balance Sheet | ||||||
| Total Assets | 9.75B | 9.28B | 9.69B | 9.30B | 10.01B | 10.05B |
| Cash, Cash Equivalents and Short-Term Investments | 452.00M | 482.00M | 672.00M | 688.00M | 1.01B | 1.45B |
| Total Debt | 1.05B | 1.45B | 1.53B | 1.88B | 2.03B | 1.79B |
| Total Liabilities | 3.90B | 3.75B | 3.95B | 4.13B | 4.62B | 5.29B |
| Stockholders Equity | 5.85B | 5.53B | 5.74B | 5.17B | 5.39B | 4.77B |
Cash Flow | ||||||
| Free Cash Flow | 316.00M | 0.00 | 742.00M | 355.00M | -49.00M | 446.00M |
| Operating Cash Flow | 400.00M | 310.00M | 1.38B | 781.00M | 406.00M | 1.23B |
| Investing Cash Flow | -68.00M | -146.00M | -636.00M | -444.00M | -451.00M | -782.00M |
| Financing Cash Flow | -362.00M | -206.00M | -798.00M | -631.00M | -487.00M | -634.00M |
Nolato AB Technical Analysis
Negative
61.20
Price Trends
48.87
Negative
50.32
Negative
54.07
Negative
Market Momentum
-0.13
Positive
45.67
Neutral
19.21
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NOLA.B, the sentiment is Negative. The current price of 61.2 is above the 20-day moving average (MA) of 49.49, above the 50-day MA of 48.87, and above the 200-day MA of 54.07, indicating a bearish trend. The MACD of -0.13 indicates Positive momentum. The RSI at 45.67 is Neutral, neither overbought nor oversold. The STOCH value of 19.21 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:NOLA.B.
Nolato AB Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | kr7.62B | 33.70 | 15.16% | ― | 18.06% | 10.57% | |
69 Neutral | kr14.70B | 37.15 | 4.54% | ― | 6.11% | 79.07% | |
58 Neutral | kr13.05B | 17.20 | 14.22% | 2.48% | -3.19% | 9.21% | |
58 Neutral | kr13.21B | -2.63 | 3.34% | 0.80% | -5.68% | -1106.19% | |
57 Neutral | kr19.23B | 33.83 | 7.24% | 0.46% | -0.32% | 83.82% | |
53 Neutral | kr20.75B | -40.13 | 3.08% | 4.25% | -7.22% | -317.94% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
SE:NOLA.B
Nolato AB
48.45
-8.31
-14.65%
SE:EKTA.B
Elekta AB
54.30
5.98
12.38%
SE:VITR
Vitrolife AB
97.50
-56.71
-36.78%
SE:ALIF.B
AddLife AB
157.70
-33.32
-17.44%
SE:MCAP
MedCap AB
505.50
73.50
17.01%
SE:VIMIAN
Vimian Group AB
27.95
-15.79
-36.10%
Nolato AB Corporate Events
Nolato names Anders Björklund CEO as long-time chief steps down
May 24, 2026
Nolato has appointed Anders Björklund as its new President and CEO, succeeding long-serving chief executive Christer Wahlquist, who will step down in connection with the half-year report in July 2026. Björklund, currently head of the Eng...
Nolato AGM Approves Dividend, Board Changes and Share Issue Mandate
May 6, 2026
Nolato AB held its Annual General Meeting on 6 May 2026, where shareholders approved all proposals from the Board and Nomination Committee, including a dividend of SEK 1.70 per share, with payment scheduled via Euroclear in mid-May. The AGM also a...
Nolato Delivers Stable Q1 Margins and Bolsters Cash Flow Amid Expansion Drive
May 6, 2026
Nolato reported first-quarter 2026 sales of SEK 2,357 million, slightly down year-on-year in nominal terms but up 3% adjusted for currency, with an unchanged EBITA margin of 11.0% and profit after tax of SEK 181 million. Despite higher input costs...
Nolato Sets May 6 Webcast for Q1 2026 Interim Report
Apr 29, 2026
Nolato AB will release its interim report for the first quarter of 2026 on Wednesday, May 6 at 1:00 p.m. CEST and will follow up with an English-language webcast conference call at 1:30 p.m. CEST the same day. President and CEO Christer Wahlquist ...
Nolato Publishes 2025 Annual and Sustainability Report Under EU CSRD Rules
Apr 9, 2026
Nolato AB has published its 2025 annual report, which includes a statutory sustainability report prepared under Sweden’s Annual Accounts Act and the EU’s new Corporate Sustainability Reporting Directive and related reporting standards....
Nolato Calls 2026 AGM with Expanded Voting Options and Capital Mandate Proposal
Apr 1, 2026
Nolato AB has convened its Annual General Meeting for 6 May 2026 in Grevie, Sweden, allowing shareholders to participate either in person, by proxy or via postal voting in line with its Articles of Association. Shareholders must be registered with...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.